European Stocks Fall for a Fourth Straight Day as Drug Shares Slide
Direct answer
European shares fell again on Thursday, November 19, 2026. The pan-European STOXX 600 index closed down 0.88% at 638.41 points. That was its fourth daily fall in a row, and its lowest close since October 23. Chip shares rose early in the day, but drug shares fell hard, and the wider market gave back its early gains.
What happened
European markets opened higher on Thursday. Investors were cheered by the record debut of Anthropic, the AI company behind the Claude chatbot, on the Nasdaq. Chip shares rose in early trading. Dutch chip equipment maker ASML gained 2.2%, STMicroelectronics rose about 2%, and Germany’s Infineon edged up.
The early lift did not last. As the session went on, selling spread across the market. Reuters reported that the STOXX 600 ended down 5.64 points, or 0.88%, at 638.41. It was the fourth session in a row that the index closed lower, and the lowest close in about four weeks.
Drug shares were the biggest drag. Swiss drugmaker Novartis fell 3.2% after it set its medium-term sales growth target at the low end of its earlier range. French drugmaker Sanofi fell 2.9% after reports that it is weighing a takeover of US drugmaker Insmed. SAP, Europe’s biggest software maker, also fell. Defensive sectors such as utilities and healthcare lagged the wider market.
The fall in Europe matched a weak day in the United States, where the Dow dropped more than 1,100 points and the S&P 500 fell for a sixth straight day. European stocks suffered their worst day since March on Wednesday, when tech shares tumbled 3.9%.
Why it matters for beginners
Four straight days of falls tell a simple story. Investors are turning cautious. The excitement around AI and the Anthropic debut was strong enough to lift chip shares in the morning, but it was not strong enough to hold the whole market up.
For beginners, the lesson is that one strong company or one hot theme does not lift every stock. Drug shares fell for their own reasons, Novartis trimmed its growth target and Sanofi is linked to a possible takeover, and those company stories mattered more than the mood around AI.
A four-week low also matters. It means the market is now below where it stood a month ago, so the recent trend is down, not just one bad day.
What to watch next
Watch whether European shares steady on Friday or fall for a fifth straight day. The final reading of US consumer sentiment for November is due on Friday, and it could move markets. Also watch the STOXX 600 level of 638.41, since a further fall would deepen the losing run. And watch the next signals from the Federal Reserve, since rate hike expectations are driving much of the recent selling.
FAQ
What is the STOXX 600?
The STOXX 600 is a broad index of 600 large, mid-sized and small companies from 17 European countries. When it falls, it means most European shares fell that day.
Why did drug shares fall?
Novartis fell 3.2% after it set its medium-term sales growth target at the low end of its earlier range, which disappointed investors. Sanofi fell 2.9% after reports that it may buy US drugmaker Insmed.
Why did chip shares rise early and then fade?
Chip shares rose in the morning on excitement around Anthropic’s record IPO debut in the United States. ASML gained 2.2% and STMicroelectronics rose about 2%. But the gains narrowed as the wider market turned lower, and the index still closed down.
What does a four-week low mean?
It means the STOXX 600 closed at its lowest level since October 23. It is a simple way to see that the market has given back about a month of gains.
